跳至主要内容
临床试验/NCT01427296
NCT01427296已完成4 期

A Phase 4, Randomized, Active Comparator, Open-Label, Multicenter Study to Assess the Safety and Efficacy of OsmoPrep® Tablets Versus HalfLytely® and Bisacodyl Tablet Bowel Prep Kit for Colon Cleansing

Bausch Health Americas, Inc.0 个研究点目标入组 2,154 人开始时间: 2011年9月16日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
2,154
主要终点
Distribution of the Overall Colon-cleansing Scale in Each Treatment Group.

研究概览

简要总结

The purpose of this study is to compare the safety and efficacy of OsmoPrep tablets versus HalfLytely and Bisacodyl Tablet Bowel Prep Kit in subjects who are undergoing colonoscopy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Between 18 and 70 years of age, inclusive
  • Scheduled for colonoscopy within 21 days of the screening visit
  • Able to swallow tablets the size of a multivitamin without difficulty

排除标准

  • History of biopsy-proven acute phosphate nephropathy
  • Known allergy or hypersensitivity to treatment arms
  • History of gastric stapling or bypass procedure or history of gastric retention
  • History of any other sodium phosphate preparation within 6 months prior to colonoscopy

研究组 & 干预措施

OsmoPrep Tablets

Active Comparator

干预措施: Oral sodium phosphate solution (Drug)

HalfLytely and Bisacodyl Tablet

Active Comparator

干预措施: Polyethylene glycol (Drug)

结局指标

主要结局

Distribution of the Overall Colon-cleansing Scale in Each Treatment Group.

时间窗: 6 months

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

相似试验